WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsMiniMed Group, Inc. Common Stock (MMED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 347% more annual revenue ($12.91B vs $2.89B). BTSG leads profitability with a 148.0% profit margin vs -7.3%. BTSG earns a higher WallStSmart Score of 54/100 (C-).

BTSG

Buy

54

out of 100

Grade: C-

Growth: 8.7Profit: 6.0Value: 3.0Quality: 7.5
Piotroski: 5/9Altman Z: 2.62

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 5.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BTSGSignificantly Overvalued (-78.4%)

Margin of Safety

-78.4%

Fair Value

$22.46

Current Price

$41.21

$18.75 premium

UndervaluedFair: $22.46Overvalued

Intrinsic value data unavailable for MMED.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG3 strengths · Avg: 9.3/10
Profit MarginProfitability
148.0%10/10

Keeps 148 of every $100 in revenue as profit

EPS GrowthGrowth
338.3%10/10

Earnings expanding 338.3% YoY

Revenue GrowthGrowth
29.3%8/10

Revenue surging 29.3% year-over-year

MMED1 strengths · Avg: 10.0/10
Operating MarginProfitability
136.0%10/10

Strong operational efficiency at 136.0%

Areas to Watch

BTSG4 concerns · Avg: 2.8/10
Return on EquityProfitability
5.9%3/10

ROE of 5.9% — below average capital efficiency

Operating MarginProfitability
3.0%3/10

Operating margin of 3.0%

Debt/EquityHealth
1.483/10

Elevated debt levels

P/E RatioValuation
87.7x2/10

Premium valuation, high expectations priced in

MMED4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-7.3%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on Profit Margin, EPS Growth, Revenue Growth. Profitability is solid with margins at 148.0% and operating margin at 3.0%. Revenue growth of 29.3% demonstrates continued momentum.

Bull Case : MMED

The strongest argument for MMED centers on Operating Margin. Revenue growth of 13.1% demonstrates continued momentum.

Bear Case : BTSG

The primary concerns for BTSG are Return on Equity, Operating Margin, Debt/Equity. A P/E of 87.7x leaves little room for execution misses.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Free Cash Flow.

Key Dynamics to Monitor

BTSG profiles as a growth stock while MMED is a turnaround play — different risk/reward profiles.

BTSG is growing revenue faster at 29.3% — sustainability is the question.

BTSG generates stronger free cash flow (174M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BTSG scores higher overall (54/100 vs 37/100), backed by strong 148.0% margins and 29.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.

Visit Website →

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Want to dig deeper into these stocks?